RecruitingNot ApplicableNCT05973799

Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes


Sponsor

University of Cincinnati

Enrollment

10 participants

Start Date

Oct 10, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Iatrogenic hypoglycemia is still considered to be the number one barrier to effective glycemic control in patients with type 1 diabetes (T1D). In a previous study, it was observed in people without diabetes that fasting can be detrimental to the hormonal and hepatic responses to insulin-induced hypoglycemia. In the experiments described herein, the impact fasting has on hypoglycemic counterregulation in people with T1D will be determined.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how fasting (not eating for a period of time) affects the body's ability to respond to low blood sugar (hypoglycemia) in people with type 1 diabetes. When blood sugar drops too low, the body normally releases hormones like adrenaline and glucagon to raise it. In type 1 diabetes, this protective response can become blunted over time. Researchers want to know whether fasting changes how this protective response works. **You may be eligible if...** - You have a confirmed diagnosis of type 1 diabetes - You are C-peptide negative (your pancreas makes no insulin at all) - You are of any race, ethnicity, or gender - You are non-obese (BMI of 30 or less) **You may NOT be eligible if...** - You are pregnant - You smoke cigarettes - You take steroids that target inflammation (such as prednisone) - You take medications that affect adrenaline signaling (such as beta-blockers or bronchodilators) - Your blood count (hematocrit) is below 33% - You have HIV or hepatitis - You have cardiovascular or peripheral vascular disease - You have diabetic nerve damage (neuropathy), eye damage (retinopathy), or kidney damage (nephropathy) - You have another condition that your study doctor believes could interfere with the results or make participation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFasting

Subjects remain fasted prior to insulin-induced hypoglycemia.

OTHERFeeding

Subjects eat a normal breakfast and lunch prior to insulin-induced hypoglycemia.


Locations(1)

University of Cincinnati

Cincinnati, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05973799


Related Trials